J&J Covid-19 Vaccine Endorsed by CDC Advisers
By Peter Loftus
A federal vaccine advisory panel voted Sunday to add Johnson
& Johnson's newly authorized Covid-19 vaccine to the arsenal of
preventive weapons against the coronavirus.
The recommendation, by the Advisory Committee on Immunization
Practices, that adults may receive J&J's shot now moves to the
director of the U.S. Centers for Disease Control and Prevention,
who is expected to formalize the policy imminently. It will be the
last step in a federal review process before the vaccine reaches
The committee voted 12-0 with one recusal in favor of wide use
of J&J's Covid-19 vaccine.
The U.S. Food and Drug Administration authorized use of the
single-dose shot on Saturday based on its 66% effectiveness at
preventing moderate to severe Covid-19 disease in a large study
that also showed it was safe.
More to follow
(END) Dow Jones Newswires
February 28, 2021 15:49 ET (20:49 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.